Treatment of Bone Metastases of Breast Cancer With 177 Lu-DOTA-IBA.
Clin Nucl Med
; 49(7): 659-661, 2024 Jul 01.
Article
em En
| MEDLINE
| ID: mdl-38537210
ABSTRACT
ABSTRACT Bone metastasis of breast cancer often presents as osteolytic. 177 Lu-DOTA-ibandronic acid ( 177 Lu-DOTA-IBA) is a new radioactive drug for bone metastasis lesion. We report a case of recurrent intermittent pain due to bone metastasis, who demonstrated a satisfactory therapy response after 2 cycles of 177 Lu-DOTA-IBA. In addition, the patient did not have any observable adverse effects.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Neoplasias Ósseas
/
Neoplasias da Mama
Limite:
Female
/
Humans
/
Middle aged
Idioma:
En
Revista:
Clin Nucl Med
Ano de publicação:
2024
Tipo de documento:
Article